ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, cilt.95, sa.1, ss.33-37, 2005 (SCI-Expanded)
Background: Cyclooxygenase-2 (COX-2) inhibitors are reported to be well tolerated in patients with analgesic intolerance (AI). However, limited data are available about the long-term tolerability of these drugs.